Under construction – not a live service

Skip to content

Frontlight Research

Trial site

Coimbra, Portugal

Coimbra, 3000-548, PortugalNot linked to an institution yet

1running trial

The trials here

What the trial at this site is about, from its registry record.

Conditions: Diabetic eye disease

Running trials

Active, not recruiting
A Study to Evaluate the Efficacy and Safety of 2 Doses of Remigromig (EYE103) Compared With Ranibizumab (0.5 mg) in Participants With DME
NCT06571045· Phase 2/3· EyeBiotech Ltd.· Source

Site data: ClinicalTrials.govUpdated 11 Nov 2026

Report an error

Under construction, not live – Coimbra, Portugal: trial site – Frontlight Research